David W. Ghesquiere
Net Worth

Last updated:

What is David W. Ghesquiere net worth?

The estimated net worth of Mr. David W. Ghesquiere is at least $5,387,490 as of 16 Mar 2020. He has received compensation worth at least $5,387,490 in NanoString Technologies, Inc..

What is the salary of David W. Ghesquiere?

Mr. David W. Ghesquiere salary is $598,610 per year as Senior Vice President of Corporation & Bus. Devel. in NanoString Technologies, Inc..

How old is David W. Ghesquiere?

Mr. David W. Ghesquiere is 58 years old, born in 1967.

What stocks does David W. Ghesquiere currently own?

As insider, Mr. David W. Ghesquiere owns shares in one company:

Company Title Shares Price per share Total value
NanoString Technologies, Inc. (NSTG) Senior Vice President of Corporation & Bus. Devel. 54,169 $0 $0

What does NanoString Technologies, Inc. do?

NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.

NSTG logo
NSTG
NanoString Technologies, Inc.

David W. Ghesquiere insider trading

NanoString Technologies, Inc.

Mr. David W. Ghesquiere has made 7 insider trades between 2016-2020, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 22,000 units of NSTG stock on 27 Feb 2020. As of 16 Mar 2020 he still owns at least 54,169 units of NSTG stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 3,177 N/A N/A
Option
Common Stock 3,177 N/A N/A
Option
Restricted Stock Units 18,039 N/A N/A
Option
Restricted Stock Units 18,039 N/A N/A
Option
Common Stock 18,039 N/A N/A
Option
Common Stock 18,039 N/A N/A
Option
Restricted Stock Units 3,334 N/A N/A
Option
Common Stock 3,334 N/A N/A
Sale
Common Stock 22,000 N/A N/A
Option
Common Stock 22,000 N/A N/A
Option
Stock Option (right to buy) 22,000 N/A N/A
Option
Stock Option (right to buy) 19,279 N/A N/A
Option
Common Stock 19,279 N/A N/A
Sale
Common Stock 19,279 N/A N/A
Option
Common Stock 300 N/A N/A
Option
Stock Option (right to buy) 300 N/A N/A
Sale
Common Stock 300 N/A N/A
Option
Common Stock 2,500 N/A N/A
Option
Restricted Stock Units 2,500 N/A N/A
Option
Common Stock 18,421 N/A N/A
Option
Stock Option (right to buy) 15,250 N/A N/A
Option
Stock Options (right to buy) 3,171 N/A N/A
Option
Common Stock 18,421 $20.75 $382,236
Sale
Common Stock 18,421 N/A N/A
Sale
Common Stock 13,908 N/A N/A
Option
Stock Options (right to buy) 6,954 N/A N/A
Option
Common Stock 6,954 N/A N/A
Option
Common Stock 18,039 N/A N/A
Option
Restricted Stock Units 18,039 N/A N/A
Option
Restricted Stock Units 3,333 N/A N/A
Option
Common Stock 3,333 N/A N/A
Option
Restricted Stock Units 4,168 N/A N/A
Option
Common Stock 4,168 N/A N/A
Option
Restricted Stock Units 2,500 N/A N/A
Option
Common Stock 2,500 N/A N/A
Option
Common Stock 3,333 N/A N/A
Option
Restricted Stock Units 3,333 N/A N/A
Option
Common Stock 5,000 N/A N/A
Option
Restricted Stock Units 5,000 N/A N/A
Option
Common Stock 4,166 N/A N/A
Option
Restricted Stock Units 4,166 N/A N/A
Sale
Common Stock 689 N/A N/A
Option
Restricted Stock Units 2,500 N/A N/A
Option
Common Stock 2,500 N/A N/A
Option
Common Stock 5,000 N/A N/A
Option
Restricted Stock Units 5,000 N/A N/A
Option
Common Stock 4,166 N/A N/A
Option
Restricted Stock Units 4,166 N/A N/A
Option
Restricted Stock Units 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Sale
Common Stock 1,321 N/A N/A

NanoString Technologies key executives

NanoString Technologies, Inc. executives and other stock owners filed with the SEC: